Clinical Trials Search Results | Moffitt

Disease Site

Keyword

Study Type

Medication

Therapy

Principal Investigator

NCT#

Study Phase

1

2

3

4

28 Clinical Trials Found

Order By

Clinical Trial 23098

A Phase IB Clinical Study of TBio-4101 (Autologous Selected and Expanded Tumor-Infiltrating Lymphocytes [TIL]) and Pembrolizumab with or without chemotherapy in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Cancer (HNSCC)

Disease Site: Eye and Orbit, Lip, Oral Cavity and Pharynx

PI: Kirtane, Kedar

Clinical Trial 20578

A Single-Arm, Open-Label, Phase 1/2 Study Evaluating the Safety, Efficacy, and Cellular Kinetics/Pharmocodynamics of ALLO-501A, an Anti-CD19 Allogeneic Car T Cell Therapy in Subjects with Relapsed/Refractory Large B-Cell Lymphoma (LBCL)

Disease Site: Lymphoma, Non-Hodgkin's Lymphoma

PI: Locke, Frederick

Clinical Trial 21971

Phase I Clinical Trial of CD40L-augmented Tumor Infiltrating Lymphocytes (CD40L TIL) for Patients with Oncogene-Driven Advanced Non-Small Cell Lung Cancer (NSCLC)

Disease Site: Lung

PI: Creelan, Benjamin

Clinical Trial 22319

A Phase 1B/2 Open-Label Study to Investigate the Safety, Tolerance and Efficacy of Drug Resistant Immunotherapy with Activated, Gene Modified Allogeneic or Autologous gamma delta T Cells (DELTEX) in Combination with Maintenance Temozolomide in Subjects with Recurrent or Newly Diagnosed Glioblastoma

Disease Site: Brain and Nervous System

PI: Liu, James